why choose us

First received: February 16, 2023

Clinical Trial: Small Sample?Unicentric?Randomized, Controlled Clinical Study of Coenzyme I for Injection in the Treatment of Sudden Sensorineural Hearing Loss

Study Status: Completed

Recruit Status: RECRUITING

Condition: Sudden Sensorineural Hearing Loss

Study Type: INTERVENTIONAL


Official Title: Small Sample?Unicentric?Randomized, Controlled Clinical Study of Coenzyme I for Injection in the Treatment of Sudden Sensorineural Hearing Loss

Brief Summary: Sudden sensorineural hearing loss is one of the most common emergencies in otorhinolaryngology, and its incidence is increasing year by year and tends to be younger.At present, the pathogenesis of sudden deafness is not clear and the individual treatment effects vary significantly.In order to break through this specific treatment bottleneck, this project pioneered the clinical application of the co-regulator nicotinamide adenine dinucleotide (NAD+) in the treatment of sudden deafness.Therefore, this project…

Read more